Therapeutic use of the LNG IUS, and counseling
- PMID: 11727178
- DOI: 10.1055/s-2001-18644
Therapeutic use of the LNG IUS, and counseling
Abstract
The intrauterine release of levonorgestrel (LNG) alters the function of the endometrium. This phenomenon offers special health benefits for users and a manner of local intrauterine therapy. In this review we discuss use of LNG-releasing intrauterine system (LNG IUS) in treatment and prevention of anemia and in the therapy of menorrhagia and dysmenorrhea. The antiproliferative effect of the LNG IUS on the endometrium offers targeted therapy against the proliferative action of estrogen on the endometrium during hormone replacement therapy. The LNG IUS as an alternative to sterilization is also discussed. There are also promising therapeutic fields such as use of the LNG IUS in the treatment of endometriosis and in the protection of endometrium exposed to tamoxifen during breast cancer treatment. Special attention is paid to counseling because successful use of the LNG IUS requires good training of the providers and extensive counseling of users.
Similar articles
-
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.Eur J Obstet Gynecol Reprod Biol. 2006 Mar 1;125(1):9-28. doi: 10.1016/j.ejogrb.2005.10.029. Epub 2005 Dec 1. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16325993 Review.
-
The levonorgestrel intrauterine system: the benefits of reduced bleeding.Eur J Contracept Reprod Health Care. 2001 Jan;6 Suppl 1:27-32. Eur J Contracept Reprod Health Care. 2001. PMID: 11336431 Review.
-
Treatment of menorrhagia with an LNG-IUS.Contraception. 2007 Jun;75(6 Suppl):S118-22. doi: 10.1016/j.contraception.2007.01.008. Epub 2007 Mar 29. Contraception. 2007. PMID: 17531601 Review.
-
Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.Aust N Z J Obstet Gynaecol. 2007 Aug;47(4):335-40. doi: 10.1111/j.1479-828X.2007.00747.x. Aust N Z J Obstet Gynaecol. 2007. PMID: 17627692 Clinical Trial.
-
Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.Adv Drug Deliv Rev. 2009 Aug 10;61(10):808-12. doi: 10.1016/j.addr.2009.04.022. Epub 2009 May 13. Adv Drug Deliv Rev. 2009. PMID: 19445984 Review.
Cited by
-
Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review.Arch Gynecol Obstet. 2023 Jun;307(6):1747-1761. doi: 10.1007/s00404-022-06640-y. Epub 2022 Jun 18. Arch Gynecol Obstet. 2023. PMID: 35716207 Free PMC article.
-
Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.Drug Saf. 2004;27(15):1185-204. doi: 10.2165/00002018-200427150-00003. Drug Saf. 2004. PMID: 15588115
-
Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use.Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006034. doi: 10.1002/14651858.CD006034.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2022 Aug 26;8:CD006034. doi: 10.1002/14651858.CD006034.pub3. PMID: 17054271 Free PMC article. Updated.
-
Efficacy and safety of long-acting reversible contraception.Drugs. 2011 May 28;71(8):969-80. doi: 10.2165/11591290-000000000-00000. Drugs. 2011. PMID: 21668037 Free PMC article. Review.
-
Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.J Clin Med. 2022 Oct 1;11(19):5836. doi: 10.3390/jcm11195836. J Clin Med. 2022. PMID: 36233703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources